'HowTo’ Choose: PD-1 and PD-L1 Inhibitors in Advanced Cutaneous Squamous Cell Carcinoma: Microlearning CME Activity

Releases on
April 23, 2026
Starts at
9:00am EDT
Earn up to
0.25 AMA PRA Category 1 Credit™
A ‘HowTo’ activity delivers a short burst of engaging and compact content for learners to study at their own convenience. In less than 15 minutes, this expert-led, microlearning activity provides a guide for ‘HowTo’ integrate new and emerging therapies for squamous cell carcinomas into your clinical decision-making.
This activity is supported by an educational grant from Sun Pharmaceutical Industries Ltd.